Sonja Fiesel

Title: Sonja Fiesel: Innovator in Heart Failure Diagnostics

Introduction

Sonja Fiesel is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the area of heart failure. Her innovative work has led to the development of a unique antibody that plays a crucial role in diagnosing heart conditions.

Latest Patents

Sonja Fiesel holds a patent for "Antibodies recognizing genetic variants of NT-proBNP." This patent describes an antibody that specifically binds to a mutated NT-proBNP, which includes mutations substituting arginine at position 46 with histidine and substituting glutamic acid at position 43 with aspartic acid. The patent also encompasses a mutated NT-proBNP or its fragments, as well as kits containing the antibody and the mutated NT-proBNP. Furthermore, the patent outlines a method for diagnosing heart failure, showcasing her innovative approach to addressing critical health issues.

Career Highlights

Sonja Fiesel is associated with Roche Diagnostics Operations, Inc., where she continues to advance her research and development efforts. Her work at Roche has positioned her as a key player in the field of diagnostics, contributing to the company's reputation for innovation and excellence in healthcare solutions.

Collaborations

Throughout her career, Sonja has collaborated with notable colleagues, including Klaus Hallermayer and Monika Soukupova. These collaborations have further enhanced her research and have contributed to the successful development of her patented technologies.

Conclusion

Sonja Fiesel's contributions to the field of heart failure diagnostics through her innovative patents and collaborations highlight her importance as an inventor. Her work not only advances medical science but also has the potential to improve patient outcomes significantly.